DIGITAL EDITION

ARCHIVES

Month: June 2013

Editor’s Message: Issue Highlights, May–June 2013

Dear Colleagues: Welcome to the May–June 2013 issue of Innovations in Clinical Neuroscience.

A Probable Case of Peduncular Hallucinosis Secondary to a Cerebral Peduncular Lesion Successfully Treated with an Atypical Antipsychotic

by Farid Ramzi Talih, MD Dr. Talih is Assistant Professor of Psychiatry at the Department of Psychiatry of the American University of Beirut Medical Center, Beirut, Lebanon. Innov Clin Neurosci.

Clinical Implications of the New Diagnostic Guidelines for Dementia

by Edmund Howe, MD, JD Dr. Howe is Professor, Department of Psychiatry, Director, Programs in Medical Ethics, and Senior Scientist, Center for the Study of Traumatic Stress, Uniformed Services University

Letter to the Editor: Valproate-Induced Hyperammonemic Encephalopathy—A Case Report

Vikas Mangewala, MD; Sajjad Sarwar, MD; Ryan Rosenberger; Theodor Rais, MD; and Michele Knox, PhD Drs. Mangewala and Sarwar are Fellows, Child and Adolescent Psychiatry; Mr. Rosenberger is a medical

Defining a Clinically Meaningful Effect for the Design and Interpretation of Randomized Controlled Trials

by Richard S. E. Keefe, PhD; Helena C. Kraemer, PhD; Robert S. Epstein, MD, MS; Ellen Frank, PhD; Ginger Haynes, PhD; Thomas P. Laughren, MD; James McNulty, AbScB; Shelby D.

How Can Registries Contribute to the Development and Evaluation of CNS Therapeutics?

by Joanne B. Severe, MS, and Annette Stemhagen, DrPH, FISPE Ms. Severe is a research consultant in Rockville, Maryland, and Dr. Stemhagen is with United Biosource Corp. in Bethesda, Maryland.